Aselizumab
Aselizumab
Aselizumab (pronunciation: a-sel-i-zoo-mab) is a monoclonal antibody designed for the treatment of various autoimmune diseases.
Etymology
The name "Aselizumab" is derived from the International Nonproprietary Names (INN), where "zu" refers to humanized antibody, "mab" stands for monoclonal antibody, and "asel" is a unique stem for the drug.
Function
Aselizumab works by targeting and inhibiting specific proteins that contribute to the pathogenesis of autoimmune diseases. It is a type of biologic therapy that uses the body's immune system to fight diseases.
Related Terms
- Monoclonal Antibodies: These are antibodies made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope.
- Autoimmune Diseases: These are conditions in which your immune system mistakenly attacks your body. The immune system normally guards against germs like bacteria and viruses.
- Biologic Therapy: This is a type of treatment that uses substances made from living organisms to treat disease. These substances may occur naturally in the body or may be made in the laboratory.
See Also
External links
- Medical encyclopedia article on Aselizumab
- Wikipedia's article - Aselizumab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski